Wheat Whisperer, circa 1953

The Green Revolution of the 20th century began with Norman Borlaug’s development of a short-statured, large-grained wheat.

Written byRina Shaikh-Lesko
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SHRINKING WHEAT: The development of short-statured wheat began with a semidwarf variety called Norin 10. Norman Borlaug bred Norin 10 with multiple other varieties to select for those that had both strong, stocky stems and good agronomic features. This photo shows the widely varying progeny of a cross between Chapingo 53, a tall variety of wheat that was resistant to a fungal pathogen called stem rust, and a variety developed from previous crosses of Norin 10 with four other wheat strains.CMMYTAs an Iowa farm boy who lived through the Great Depression, Norman Borlaug viscerally understood the toll of poverty and hunger. It fueled his determination to feed a global population that was increasing exponentially—and his tenacious belief that the way to do so was by boosting crop yields.

Trained as a plant pathologist, Borlaug joined the Rockefeller Institute–funded Cooperative Wheat Research and Production Program in Mexico (a precursor to CIMMYT, the International Maize and Wheat Improvement Center) in 1944 to develop varieties resistant to a fungal pathogen called wheat rust. (See “Putting Up Resistance,” page 34.) He succeeded, but the tall varieties he worked with tended to fall over, or “lodge,” in the wind or rain when the seed heads grew large. In 1953, Borlaug obtained a Japanese variety of semidwarf wheat called Norin 10, which was two feet shorter. He first bred Norin 10 with local rust–resistant Mexican strains, and eventually crossed the hybrids with wheat varieties from other countries. This painstaking work continued for years, but yielded wheat with plump heads ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies